“CSL Behring - Canada Research Chair in Endothelial Cell Biology to ... - CNW Group” plus 4 more

---

• CSL Behring - Canada Research Chair in Endothelial Cell Biology to ... - CNW Group
• 3 Americans share 2009 Nobel medicine prize - Detroit Free Press
• 3 Americans Win Nobel Prize For Medicine - CBS 2 KCAL 9
• 3 Americans Share Nobel in Medicine - AOL
• U.S. scientists win Nobel Prize-medicine - United Press International

CSL Behring - Canada Research Chair in Endothelial Cell Biology to ... - CNW Group Posted: 05 Oct 2009 05:33 AM PDT Position established to address unmet needs in treating bleeding and immune system disorders VANCOUVER, Oct. 5 /CNW/ -- The Centre for Blood Research (CBR) and the Faculty of Medicine at the University of British Columbia have announced the establishment of the CSL Behring - Canada Research Chair in Endothelial Cell Biology. Over the next five years, the CBR and CSL Behring Canada, the biopharmaceutical company co-funding the chair program, will collaborate on the research and development of new therapies for patients with bleeding and immune system disorders. The CSL Behring - Canada Research Chair in Endothelial Cell Biology, a professorship created through the Canada Research Chairs program, will be held by the newly appointed Director of the CBR, physician-scientist Edward Conway, MD, PhD, MBA. "The Canada Research Chairs program brings together the unique skills of both industry and academia," said Dr. Conway, Director of the Centre for Blood Research and Professor of Medicine in the Division of Hematology, Faculty of Medicine at the University of British Columbia. "Through our combined efforts, we intend to promote first-class education, training, and research for the management of bleeding and immune system disorders, all of which will accelerate delivery of new discoveries in these fields in Canada and throughout the world." Dr. Conway trained as a hematologist-oncologist at the University of Toronto and at Harvard University and has been a staff physician-scientist in Toronto and more recently at the University of Leuven in Belgium, where he received his PhD. His scientific interests involve studies of the vasculoprotective properties of the endothelium and its interactions with multiple biological systems. Dr. Conway has wide expertise in the fields of coagulation, vascular biology, angiogenesis, inflammation, and innate immunity. "CSL Behring Canada is proud to partner with the University of British Columbia to establish this scientifically important chair," said Dr. Heinz Neuhaus, General Manager, CSL Behring Canada. "The CBR goals align with CSL Behring's mission to develop safe and effective therapies that improve the lives of patients with rare and serious diseases, and we look forward to a productive collaboration." Created as a permanent program in 2000, the Canada Research Chairs program was designed by the Government of Canada to encourage research and development in Canada. Since its inception, the program has allowed chairpersons to improve Canadians' depth of knowledge and quality of life, strengthen the country's international competitiveness and help train the next generation of highly skilled people. There are currently 1,796 research professorships at 70 universities across Canada. "We are delighted that this important collaboration between academia, industry and support from the federal government has helped to repatriate Dr. Conway back to Canada. Special thanks to Dr. Dana Devine (Vice-President of Medical, Scientific and Research Affairs for Canadian Blood Services) and Dr. Ross MacGillivray (newly named Vice- Dean Academic Affairs for the Faculty, Professor in the Department of Biochemistry and Molecular Biology) who were instrumental in securing this gift," said Dr. Gavin Stuart, UBC Vice Provost Health and Dean, Faculty of Medicine. About the Centre for Blood Research (CBR) The University of British Columbia (UBC) Centre for Blood Research (CBR) was established in 2002 and is currently the largest inter-disciplinary blood research centre in the world. Current membership involves 42 investigators from the Faculties of Applied Science, Arts, Dentistry, Medicine, Pharmaceutical Sciences and Science, and some with appointments at the University of Victoria and the University of Northern British Columbia. CBR investigators are mainly located in Vancouver at the Life Sciences Centre and other buildings on the UBC campus and the associated teaching hospitals and BC Cancer Agency. The mission of the CBR is to provide leading edge biomedical research, training, education, and innovative technologies for accelerated delivery of affordable, safe, high-quality diagnostics, therapeutics and medical care. Specific areas of interest include applying emerging biotechnologies to the study of blood and blood processing for the creation of new knowledge in transfusion science; developing safer means of removing excess iron from blood; identifying risk factors, biomarkers and therapies for innate immune, inflammatory, malignant, hemostatic and thrombotic disorders; developing novel approaches to repair vascular system abnormalities; designing microbe-resistant drugs for a range of viruses, parasites and bacteria; restoring organ function with stem cell technologies; modulating the immune system for better management of chronic inflammatory diseases; improving drug production technologies; and establishing integrated research and clinical training programs to better manage the significant medical problems that confront our society. About the Faculty of Medicine at UBC The University of British Columbia is home to the province's only medical school. It provides innovative educational and research programs in the areas of health and life sciences through an integrated and province-wide delivery model. Founded in 1950 with a graduating class of 60 students, it now has more than 2,590 students at the undergraduate, graduate and postgraduate levels and provides teaching to several thousand additional students from other disciplines at UBC. www.med.ubc.ca About CSL Behring Canada Committed to saving lives and improving the quality of life for people with rare and serious diseases, CSL Behring manufactures and markets a range of plasma-derived and recombinant therapies worldwide. As a global leader in the plasma protein therapeutics industry, the company offers a wide range of plasma-derived and recombinant therapeutic products including a variety of products used in the hospital setting for critical care, for primary immunological disorders, and as thrombolytic agents. The company also operates one of the world's largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.com. Media Contact: Laura de Zutter 1-800-477-9626 MCS Public Relations For further information: Laura de Zutter of MCS Public Relations, 800-477-9626 Web Site: http://www.med.ubc.ca

3 Americans share 2009 Nobel medicine prize - Detroit Free Press Posted: 05 Oct 2009 06:01 AM PDT STOCKHOLM Americans Elizabeth Blackburn, Carol Greider and Jack Szostak were named winners of the 2009 Nobel Prize in medicine on Monday for research that has implications for cancer and aging research. The trio solved a big problem in biology: how chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation, the citation said. It said the laureates have shown that the solution is to be found in the ends of the chromosomes the telomeres and in an enzyme that forms them. Telomeres are often compared to the plastic tips at the end of shoe laces that keep those laces from unraveling. The discoveries by Blackburn, Greider and Szostak have added a new dimension to our understanding of the cell, shed light on disease mechanisms, and stimulated the development of potential new therapies, the prize committee said in its citation. Blackburn, who holds U.S. and Australian citizenship, is a professor of biology and physiology at the University of California, San Francisco. Greider is a professor in the department of molecular biology and genetics at Johns Hopkins University School of Medicine in Baltimore. London-born Szostak has been at Harvard Medical School since 1979 and is currently professor of genetics at Massachusetts General Hospital in Boston. He is also affiliated with the Howard Hughes Medical Institute, the citation said. The award, announced today, includes a $1.4-million purse, a diploma and an invitation to the prize ceremonies in Stockholm on Dec. 10. The Nobel Prizes in physics, chemistry, literature and the Nobel Peace Prize will be announced later this week, while the economics award will be presented on Oct. 12. Prize founder Alfred Nobel, a Swedish industrialist who invented dynamite, left few instructions on how to select winners, but medicine winners are typically awarded for a specific breakthrough rather than a body of research. Nobel established the prizes in his will in 1895. The first awards were handed out six years later.

3 Americans Win Nobel Prize For Medicine - CBS 2 KCAL 9 Posted: 05 Oct 2009 06:23 AM PDT E-mail Close Window E-mail This Page The following page was sent to 3 Americans Win Nobel Prize For Medicine A copy was sent to your e-mail address Send Another E-mail    Print     Share +  Digg  Facebook Stumble It! del.icio.us  Fark  Twitter    3 Americans Win Nobel Prize For Medicine  CBS News Interactive: Cancer  CBS News Interactive: Healthwatch STOCKHOLM (AP) ― Click to enlarge A picture taken from a screen as the Nobel Assembly at Karolinska Institute announces Elisabeth H. Blackburn, Carol W. Greider and Jack W. Szostak as the winners of the 2009 Nobel Prize in Medecine on October 5, 2009 in Stockholm. Olivier Morin/AFP/Getty Images Close Americans Elizabeth Blackburn, Carol Greider and Jack Szostak were named winners of the 2009 Nobel Prize in medicine on Monday for research that has implications for cancer and aging research. The trio solved a big problem in biology: how chromosomes can be "copied in a complete way during cell divisions and how they are protected against degradation," the citation said. It said the laureates have shown that the solution is to be found in the ends of the chromosomes - the telomeres - and in an enzyme that forms them. Telomeres are often compared to the plastic tips at the end of shoe laces that keep those laces from unraveling. "The discoveries by Blackburn, Greider and Szostak have added a new dimension to our understanding of the cell, shed light on disease mechanisms, and stimulated the development of potential new therapies," the prize committee said in its citation. Blackburn, who holds U.S. and Australian citizenship, is a professor of biology and physiology at the University of California, San Francisco. Greider is a professor in the department of molecular biology and genetics at Johns Hopkins University School of Medicine in Baltimore. London-born Szostak has been at Harvard Medical School since 1979 and is currently professor of genetics at Massachusetts General Hospital in Boston. He is also affiliated with the Howard Hughes Medical Institute, the citation said. The award, announced Monday, includes a 10 million kronor ($1.4 million) purse, a diploma and an invitation to the prize ceremonies in Stockholm on Dec. 10. The Nobel Prizes in physics, chemistry, literature and the Nobel Peace Prize will be announced later this week, while the economics award will be presented on Oct. 12. Prize founder Alfred Nobel, a Swedish industrialist who invented dynamite, left few instructions on how to select winners, but medicine winners are typically awarded for a specific breakthrough rather than a body of research. Nobel established the prizes in his will in 1895. The first awards were handed out six years later. (© 2009 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)

3 Americans Share Nobel in Medicine - AOL Posted: 05 Oct 2009 04:28 AM PDT kjdhkjhsd 10:14 AMOct 05 2009 Good morning, take your time and a little bit.Now I introduce a website =================== http://www.ebuyings.com ==================free shipping ========= competitive price ============ any size available ===========accept the paypal ==========our price:Air jordan(1-24)shoes $33UGG BOOT $50Nike shox(R4,NZ,OZ,TL1,TL2,TL3) $35Handbags(Coach lv fendi d&g) $35Tshirts (Polo ,ed hardy,lacoste) $16Jean(True Religion,ed hardy,coogi) $30Sunglasses(Oakey,coach,gucci,Armaini) $16New era cap $15Bikini (Ed hardy,polo) $25Hope everybody can choose to what you like! Happy every day !!!

U.S. scientists win Nobel Prize-medicine - United Press International Posted: 05 Oct 2009 04:28 AM PDT STOCKHOLM, Sweden, Oct. 5 (UPI) -- Three U.S. scientists earned the 2009 Nobel Prize in Physiology and Medicine for work on how chromosomes are protected, the Nobel Foundation in Sweden said. Elizabeth H. Blackburn, Carol W. Greider and Jack W. Szostak addressed a major problem in biology of how the chromosomes could be copied in a complete way during cell divisions and how they are protected against degradation, the foundation said in a news release. The laureates showed the answer lies in the telomeres and telomerase -- the ends of the chromosomes and the enzyme that forms them, the foundation said. DNA molecules carry human genes in chromosomes capped by telomeres on their ends. Blackburn and Szostak discovered that a specific DNA sequence in the telomeres protects the chromosomes from degradation. Greider and Blackburn identified telomerase, the enzyme making telomere DNA. The body of work explain how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase. The discoveries by Blackburn, Greider and Szostak have "added a new dimension to our understanding of the cell, shed light on disease mechanisms, and stimulated the development of potential new therapies," the foundation said. Blackburn has dual U.S-Australian citizenship. Since 1990, she has been professor of biology and physiology at the University of California in San Francisco. Greider was appointed professor in the department of molecular biology and genetics at Johns Hopkins University School of Medicine in Baltimore in 1997. Szostak is professor of genetics at Massachusetts General Hospital in Boston and affiliated with the Howard Hughes Medical Institute.

You are subscribed to email updates from Biology - Bing News To stop receiving these emails, you may unsubscribe now.	Email delivery powered by Google
Google Inc., 20 West Kinzie, Chicago IL USA 60610